[1]
2019. Maintenance and Improvement of Skin Clearance Response With Brodalumab Among Patients With Moderate-to-Severe Psoriasis. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S23. DOI:https://doi.org/10.25251/skin.3.supp.23.